Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Infliximab
Locations
1
United States
UCSF Medical Center
San Francisco, California, United States
Start Date
October 1, 2024
Primary Completion Date
June 1, 2027
Completion Date
December 1, 2027
Last Updated
July 8, 2025
NCT07371455
NCT06258538
NCT05093673
NCT07253181
NCT06870812
NCT04119544
Lead Sponsor
University of California, San Francisco
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions